Detalhe da pesquisa
1.
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
Ann Clin Transl Neurol;
11(5): 1338-1346, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572524
2.
Taste disorders and alopecia in myasthenia gravis.
BMC Neurol;
24(1): 139, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664714
3.
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis.
Scand J Immunol;
99(5): e13360, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605547
4.
Population-level prokaryotic community structures associated with ferromanganese nodules in the Clarion-Clipperton Zone (Pacific Ocean) revealed by 16S rRNA gene amplicon sequencing.
Environ Microbiol Rep;
16(1): e13224, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146681
5.
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
J Neuroimmunol;
385: 578241, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952282
6.
Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies.
J Neuroimmunol;
384: 578205, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774555
7.
Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies.
Muscle Nerve;
68(5): 798-804, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705312
8.
Effects of BL 23 (Shenshu) acupuncture on serum cytokine levels in healthy adults: A randomized double-blind sham-controlled phase 1 study.
J Neuroimmunol;
382: 578165, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542799
9.
Genetic population structures of common scavenging species near hydrothermal vents in the Okinawa Trough.
Sci Rep;
13(1): 2348, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759539
10.
Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis.
J Neuroimmunol;
375: 578014, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621075
11.
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis.
Neurotherapeutics;
20(2): 518-523, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607596
12.
Minimal symptom expression achievement over time in generalized myasthenia gravis.
Acta Neurol Belg;
123(3): 979-982, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592291
13.
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
J Neurol Neurosurg Psychiatry;
94(6): 467-473, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693723
14.
Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis.
Clin Neurol Neurosurg;
220: 107371, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35878561
15.
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
Scand J Immunol;
95(2): e13122, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796975
16.
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
J Neuroimmunol;
358: 577634, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174586
17.
Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.
J Neurol Neurosurg Psychiatry;
92(9): 963-968, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766920
18.
Long-term outcomes and prognostic factors in generalized myasthenia gravis.
J Neurol;
268(10): 3781-3788, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774750
19.
Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies.
Intern Med;
60(16): 2671-2675, 2021 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33642484